Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial iron–sulfur (Fe-S) cluster-containing enzymes and iron metabolism pathways represent a complex network of proteins and processes essential for bacterial survival, virulence, and adaptation to host environments. Fe-S clusters are vital inorganic cofactors that facilitate electron transfer, catalysis, and environmental sensing in enzymes involved in the TCA cycle, respiration, and DNA repair (Ezraty et al., 2017, Nature Reviews Microbiology). Because iron is scarce in the host due to nutritional immunity, bacteria utilize specialized iron acquisition systems, including the secretion of high-affinity siderophores and the expression of dedicated transporters, often regulated by the Ferric Uptake Regulator (Fur) protein (Kramer et al., 2020, Nature Reviews Microbiology). These pathways are increasingly recognized as viable therapeutic targets, particularly for addressing multi-drug resistant (MDR) pathogens. Pharmacological interventions include iron mimetics like gallium, which substitutes for iron in Fe-S clusters and enzymes to induce lethal metabolic dysfunction (Goss et al., 2018, Science Translational Medicine), and siderophore-antibiotic conjugates such as Cefiderocol that utilize bacterial iron transporters to bypass outer membrane barriers (Simner et al., 2020, Clinical Infectious Diseases). Targeting these systems offers a strategy to starve bacteria of essential nutrients or disrupt fundamental metabolic processes, though challenges remain regarding potential cross-reactivity with host iron-dependent pathways (Choi & Skaar, 2022, Nature Reviews Microbiology).
Siderophore-mediated antibiotic delivery (Trojan horse), competitive inhibition of iron-dependent enzymes, disruption of Fe-S cluster assembly and stability, and inhibition of iron uptake transporters.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial iron–sulfur cluster-containing enzymes and iron metabolism pathways.